Ultrasound findings of the sternoclavicular and shoulder joints in patients on maintenance hemodialysis.
amyloidosis
hemodialysis
shoulder joint
sternoclavicular joint
ultrasound
Journal
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
ISSN: 1744-9987
Titre abrégé: Ther Apher Dial
Pays: Australia
ID NLM: 101181252
Informations de publication
Date de publication:
12 Dec 2023
12 Dec 2023
Historique:
revised:
12
11
2023
received:
07
07
2023
accepted:
23
11
2023
medline:
12
12
2023
pubmed:
12
12
2023
entrez:
12
12
2023
Statut:
aheadofprint
Résumé
Ultrasonographic examination of joints is a non-invasive method to detect and monitor Dialysis-associated amyloidosis (DRA). An ultrasonographic examination of the sternoclavicular (SC) and shoulder joints was performed in patients on maintenance hemodialysis (MHD) and those with normal renal function in the control group. The maximum distance (D) of SC, the rotator cuff thickness (RCs), and the echogenic pads (EPs) of the shoulder were evaluated. Compared with the control group, the MHD group had a higher D of SC, a higher proportion of RCs ≥8 mm, and a higher proportion of EPs positive. Adjust for age and Kt/V, the D of SC was positively related to dialysis vintage, standardized coefficients β = 0.329, p = 0.004. A significant positive correlation existed between the D of SC and the RCs. In addition to the shoulder joint, the sternoclavicular is a suitable site for ultrasonographic detection of DRA.
Identifiants
pubmed: 38084611
doi: 10.1111/1744-9987.14093
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Basic-clinical research cooperation fund of Capital Medical University
ID : 16JL76
Informations de copyright
© 2023 International Society for Apheresis and Japanese Society for Apheresis.
Références
Kaneko S, Yamagata K. Hemodialysis-related amyloidosis: is it still relevant? Semin Dial. 2018;31(6):612-618.
Saito A, Gejyo F. Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients. Ther Apher Dial. 2006;10(4):316-320.
Gal R, Korzets A, Schwartz A, Rath-Wolfson L, Gafter U. Systemic distribution of beta 2-microglobulin-derived amyloidosis in patients who undergo long-term hemodialysis. Report of seven cases and review of the literature. Arch Pathol Lab Med. 1994;118(7):718-721.
Takayama F, Miyazaki S, Morita T, Hirasawa Y, Niwa T. Dialysis-related amyloidosis of the heart in long-term hemodialysis patients. Kidney Int. 2001;78:S172-S176.
Hoshino J, Yamagata K, Nishi S, Nakai S, Masakane I, Iseki K, et al. Significance of the decreased risk of dialysis-related amyloidosis now proven by results from Japanese nationwide surveys in 1998 and 2010. Nephrol Dial Transplant. 2016;31(4):595-602.
Jadoul M, Garbar C, Noël H, Sennesael J, Vanholder R, Bernaert P, et al. Histological prevalence of beta 2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study. Kidney Int. 1997;51(6):1928-1932.
Tsuruya K, Arima H, Iseki K, Hirakata H, Kyushu Dialysis-Related Amyloidosis Study Group. Association of dialysis-related amyloidosis with lower quality of life in patients undergoing hemodialysis for more than 10 years: the Kyushu dialysis- related amyloidosis study. PLoS One. 2021;16(8):e0256421.
Kay J, Benson CB, Lester S, Corson JM, Pinkus GS, Michael Lazarus J, et al. Utility of high-resolution ultrasound for the diagnosis of dialysis-related amyloidosis. Arthritis Rheum. 1992;35(8):926-932.
Scarpioni R, Ricardi M, Albertazzi V, de Amicis S, Rastelli F, Zerbini L. Dialysis-related amyloidosis: challenges and solutions. Int J Nephrol Renovasc Dis. 2016;9:319-328.
Rodríguez-Henríquez P, Solano C, Peña A, León-Hernández S, Hernández-Díaz C, Gutiérrez M, et al. Sternoclavicular joint involvement in rheumatoid arthritis: clinical and ultrasound findings of a neglected joint. Arthritis Care Res. 2013;65(7):1177-1182.
Donadio C, Kanaki A, Sami N, Tognotti D. High-flux dialysis: clinical, biochemical, and proteomic comparison with low-flux dialysis and on-line hemodiafiltration. Blood Purif. 2017;44(2):129-139.
Raj DS, Ouwendyk M, Francoeur R, Pierratos A. Beta (2)-microglobulin kinetics in nocturnal haemodialysis. Nephrol Dial Transplant. 2000;15(1):58-64.
Gejyo F, Amano I, Ando T, Ishida M, Obayashi S, Ogawa H, et al. Survey of the effects of a column for adsorption of beta2-microglobulin in patients with dialysis-related amyloidosis in Japan. Ther Apher Dial. 2013;17(1):40-47.
Portales-Castillo I, Yee J, Tanaka H, Fenves AZ. Beta-2 microglobulin amyloidosis: past, present, and future. Kidney360. 2020;1(12):1447-1455.
Sommer R, Valen GJ, Ori Y, Weinstein T, Katz M, Hendel D, et al. Sonographic features of dialysis-related amyloidosis of the shoulder. J Ultrasound Med. 2000;19(11):765-770.
Cardinal E, Buckwalter KA, Braunstein EM, Raymond-Tremblay D, Benson MD. Amyloidosis of the shoulder in patients on chronic hemodialysis: sonographic findings. AJR Am J Roentgenol. 1996;166(1):153-156.
Zhang D, Makhni MC, Kang JD, Blazar P. Orthopaedic manifestations of amyloidosis. J Am Acad Orthop Surg. 2021;29(10):e488-e496.
Sigaux J, Abdelkefi I, Bardin T, Laredo JD, Ea HK, UreñaTorres P, et al. Tendon thickening in dialysis-related joint arthritis is due to amyloid deposits at the surface of the tendon. Joint Bone Spine. 2019;86(2):233-238.
Bellotti V, Cetta G, Alessandra CO, Gennaro ES, Giorgetti S, Mangione P, et al. Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. Protein Sci. 2005;14(3):696-702.
Morimoto H, Wada J, Font B, Mott JD, Hulmes DJ, Ookoshi T, et al. Procollagen C-proteinase enhancer-1 (PCPE-1) interacts with beta2-microglobulin (beta2-m) and may help initiate beta2-m amyloid fibril formation in connective tissues. Matrix Biol. 2008;27(3):211-219.
Heegaard NH. Beta (2)-microglobulin: from physiology to amyloidosis. Amyloid. 2009;16(3):151-173.
Makita Z, Bucala R, Rayfield EJ, Friedman EA, Kaufman AM, Korbet SM, et al. Reactive glycosylation end products in diabetic uraemia and treatment of renal failure. Lancet. 1994;343(8912):1519-1522.
Miyata T, Inagi R, Iida Y, Sato M, Yamada N, Oda O, et al. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1. J Clin Invest. 1994;93(2):521-528.
Warren DJ, Otieno LS. Carpal tunnel syndrome in patients on intermittent haemodialysis. Postgrad Med J. 1975;51(597):450-452.